Dashboard
Poor Management Efficiency with a low ROE of 6.93%
- The company has been able to generate a Return on Equity (avg) of 6.93% signifying low profitability per unit of shareholders funds
Poor long term growth as Net Sales has grown by an annual rate of -19.70% and Operating profit at -37.29% over the last 5 years
Negative results in Sep 25
With ROE of 2.3, it has a Very Expensive valuation with a 0.4 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commodity Chemicals
INR 111 Cr (Micro Cap)
19.00
40
0.00%
-0.11
2.27%
0.43
Total Returns (Price + Dividend) 
Latest dividend: 7 per share ex-dividend date: Jul-23-2024
Risk Adjusted Returns v/s 
Returns Beta
News

AG Ventures Sees Revision in Market Assessment Amidst Challenging Financial Trends
AG Ventures, a microcap player in the Commodity Chemicals sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights shifts across key parameters including quality, valuation, financial trends, and technical indicators, underscoring the stock's continued underperformance relative to its peers and broader benchmarks.
Read More
AG Ventures Stock Falls to 52-Week Low of Rs.113.85 Amidst Continued Underperformance
AG Ventures has reached a new 52-week low of Rs.113.85, marking a significant decline in its share price amid ongoing challenges in financial performance and market positioning within the Commodity Chemicals sector.
Read More Announcements 
Outcome Of Board Meeting Dated 12.11.2025
12-Nov-2025 | Source : BSEOutcome of Board Meeting dated 12.11.2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 12 2025
12-Nov-2025 | Source : BSEThis is further to our letter dated November 04 2025 intimating the date of the Board Meeting for the approval of Un-audited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30 2025. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we would like to inform you that the Board today has approved the Un-audited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30 2025. We attach herewith a copy of the approved Un-audited (Standalone and Consolidated) Financial Results along with the Limited Review Report of the auditors.
Announcement under Regulation 30 (LODR)-Change in Directorate
06-Nov-2025 | Source : BSEPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 including amendments thereunder (Listing Regulations) this is to inform you that as per the internal guidelines and policy of Life Insurance Corporation of India (LIC) Mr. Sanjay Verma (DIN: 09784146) has completed his tenure of 3 years as prescribed by LIC and consequently he ceased to be the Nominee Director of the Company w.e.f. the closure of business hours on November 06 2025.
Corporate Actions 
No Upcoming Board Meetings
AG Ventures Ltd has declared 70% dividend, ex-date: 23 Jul 24
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (2.67%)
Held by 3 FIIs (1.26%)
Cosmopolitan Investments Private Limited (25.59%)
Hdfc Large And Mid Cap Fund (2.62%)
36.1%
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is -6.73% vs 60.15% in Sep 2024
YoY Growth in quarter ended Sep 2025 is 0.00% vs -98.01% in Sep 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 0.12% vs 29.01% in Sep 2024
Growth in half year ended Sep 2025 is -56.46% vs -70.78% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 39.73% vs -86.08% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -71.18% vs -7.56% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 33.40% vs -84.85% in Mar 2024
YoY Growth in year ended Mar 2025 is -78.84% vs 1.73% in Mar 2024







